These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28768917)

  • 41. Population pharmacokinetics of bisoprolol in patients with chronic heart failure.
    Nikolic VN; Jevtovic-Stoimenov T; Velickovic-Radovanović R; Ilic S; Deljanin-Ilic M; Marinkovic D; Apostolović S; Stanojevic D; Zivanovic S; Stefanovic N; Pesic S; Zecevic DR; Milovanovic JR; Jankovic SM
    Eur J Clin Pharmacol; 2013 Apr; 69(4):859-65. PubMed ID: 23093041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
    Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
    Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.
    Erdmann E; Lechat P; Verkenne P; Wiemann H
    Eur J Heart Fail; 2001 Aug; 3(4):469-79. PubMed ID: 11511434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the Transdermal Bisoprolol Patch with Oral Bisoprolol Fumarate Administration as a Therapeutic Agent for Idiopathic Frequent Premature Ventricular Contractions.
    Shinohara M; Wada R; Yao S; Yano K; Akitsu K; Koike H; Kinoshita T; Yuzawa H; Suzuki T; Fujino T; Ikeda T
    Int Heart J; 2020 May; 61(3):510-516. PubMed ID: 32418969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisoprolol in the treatment of chronic heart failure.
    de Groote P; Ennezat PV; Mouquet F
    Vasc Health Risk Manag; 2007; 3(4):431-9. PubMed ID: 17969374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
    Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study.
    Tsutsui H; Momomura S; Saito Y; Ito H; Yamamoto K; Ohishi T; Okino N; Guo W
    J Cardiol; 2017 Sep; 70(3):225-231. PubMed ID: 28024961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
    Miró Ò; Müller C; Martín-Sánchez FJ; Bueno H; Mebazaa A; Herrero P; Jacob J; Gil V; Escoda R; Llorens P;
    Clin Res Cardiol; 2016 Dec; 105(12):1021-1029. PubMed ID: 27379611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension.
    Kanegae K; Hiroshige K; Suda T; Iwamoto M; Ohta T; Nakashima Y; Ohtani A
    Int J Artif Organs; 1999 Dec; 22(12):798-804. PubMed ID: 10654875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II).
    Simon T; Mary-Krause M; Funck-Brentano C; Lechat P; Jaillon P
    Eur Heart J; 2003 Mar; 24(6):552-9. PubMed ID: 12643888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of bisoprolol on right ventricular function and brain natriuretic peptide in patients with heart failure.
    Beck-da-Silva L; de Bold A; Davies R; Chow B; Ruddy T; Fraser M; Struthers C; Haddad H
    Congest Heart Fail; 2004; 10(3):127-32. PubMed ID: 15184726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
    Galatius S; Gustafsson F; Atar D; Hildebrandt PR
    Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between Dose and Plasma Concentration of Bisoprolol in Patients with Heart Failure (CVI ARO 6).
    Arita T; Suzuki S; Kato Y; Kano H; Yajima J; Matsuno S; Otsuka T; Semba H; Uejima T; Oikawa Y; Nagashima K; Yagi N; Sagara K; Tanabe G; Yamashita T
    Int Heart J; 2020 Jul; 61(4):748-754. PubMed ID: 32684605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bisoprolol: a review of its use in chronic heart failure.
    McGavin JK; Keating GM
    Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.